Viveretx
Berkeley, US · Founded 2022 · 13 employees on LinkedIn · 1 known investors
Find your way into Viveretx
557 people in our graph share verified history with the Viveretx team — schools, employers, funds. One of them is your warm intro.
Kevin Wijayaunlockedknows Adam Schieferecke · together at University of California, Berkeley (overlapped)
×4knows the team · via Point72
×6knows the team · via University of California, Berkeley
knows the team · via Pepperdine Graziadio Business School
Vivere is an early-stage biotech developing cancer therapies that use a bioengineering platform (based on UC Berkeley research) to activate the immune system against "cold" solid tumors through targeted delivery. It focuses on immuno-oncology and gene/viral vector engineering to treat difficult solid cancers.
Founders & leadership
Viveretx was founded in 2022 by Adam Schieferecke, Hyuncheol Lee, David Schaffer, John Dueber, and Wanichaya Noiwangklang.
AS
Adam SchiefereckeinCo-founder; Head of ResearchAdam Schieferecke has 13 years of experience in molecular, cellular, and evolutionary virology and serves as co-founder and head of research at Vivere, a biotech company developing cancer immunotherapies using viral vector engineering.
HL
Hyuncheol LeeinCo-founder; Head of Nonclinical DevelopmentHyuncheol Lee holds a DVM and PhD and has worked on immunology, virology, and gene therapy, with expertise in viral vector development and preclinical in vivo models for disease and cancer applications.
DS
David SchafferinCo-founder; PresidentExecutive Director of QB3, Director of Bakar Labs at Berkeley Frontier
JD
John DueberCo-founder; Scientific Advisor
WN
Wanichaya NoiwangklanginCo-founder; Head of Operations
Investors · 1
Frequently asked questions
- What does Viveretx do?
- Vivere is an early-stage biotech developing cancer therapies that use a bioengineering platform (based on UC Berkeley research) to activate the immune system against "cold" solid tumors through targeted delivery. It focuses on immuno-oncology and gene/viral vector engineering to treat difficult solid cancers.
- Who founded Viveretx?
- Viveretx was founded by Adam Schieferecke, Hyuncheol Lee, David Schaffer, John Dueber, Wanichaya Noiwangklang in 2022.
- Who are Viveretx's investors?
- Viveretx's investors include Berkeley Frontier.
- Where is Viveretx headquartered?
- Viveretx is headquartered in Berkeley, US.